Immediate Impact

6 by Nobel laureates 4 from Science/Nature 69 standout
Sub-graph 1 of 16

Citing Papers

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
PARP and PARG inhibitors in cancer treatment
2020 Standout
55 intermediate papers

Works of Gordon Rustin being referenced

Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
2016 Standout
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
2014 Standout
and 17 more

Author Peers

Author Last Decade Papers Cites
Gordon Rustin 5054 3348 5247 3993 244 15.7k
Amit M. Oza 6780 2575 10496 7237 581 21.0k
Ursula A. Matulonis 8004 1561 13055 7706 424 22.4k
Gordon C. Jayson 4036 2099 4023 4664 251 13.7k
Andrew Berchuck 6748 1604 5699 8006 353 19.5k
Roman Rouzier 4033 3565 5452 2420 474 16.3k
David G. Mutch 6686 4458 4180 3879 441 18.4k
David M. Gershenson 11680 5808 5099 4102 396 21.1k
R. Kreienberg 1485 1254 4223 2058 428 10.4k
Gini F. Fleming 5227 2296 7997 4050 326 16.2k
Karen H. Lu 8090 1996 6678 7308 425 21.0k

All Works

Loading papers...

Rankless by CCL
2026